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Tightly controlled extracellular matrix (ECM) homeostasis
and remodeling is critical for normal organ homeostasis,
wound healing and tissue repair. However, excessive or
uncontrolled ECM deposition contributes to aberrant
homeostasis of tissue microenvironment in various inﬂam-
matory diseases and tumors. Matricellular proteins are a set
of structurally unrelated ECM proteins that do not exert a
primary role in tissue architecture but have regulatory roles
in embryonic development, tissue injury, inﬂammation and
tumor progression. Two recent studies demonstrated that
matricellular proteins in the ECM surrounding dormant tumor
cells may determine the fate of tumor cells to remain qui-
escent or undergo metastatic outgrowth. The identiﬁcation of
matricellular proteins in regulating ECM homeostasis and
remodeling speciﬁc organ niches during tumor dormancy
may provide potential novel extracellular targets for the
development of therapeutic interventions against tumor
dormancy.
Many cancer patients who have undergone surgical
resection of their primary tumors suffer from metastatic
relapse several months, years or even decades later. Cur-
rent evidence supports the idea that tumor cells can be
disseminated at an early stage of tumor progression. The
disseminated tumor cells (DTCs) exist in a quiescent state at
a hostile site, but may switch from quiescence to proliferative
metastatic growth in a permissive and supportive microen-
vironment. Increasing data suggest that tumor dormancy can
be regarded as a protracted asymptomatic stage during
which tumor cells either remain in a quiescent state or their
proliferation is balanced by cell death due to immunosur-
veillance or insufﬁcient angiogenesis (Aguirre-Ghiso, 2007;
Giancotti, 2013; Hensel et al., 2013) (Fig. 1). Similar to other
processes in tumorigenesis and progression, tumor dor-
mancy is governed by both intracellular signaling pathways
and tissue microenvironment cues. However, how DTCs
enter into quiescence and subsequently reactivate, as well
as which types of microenvironmental cues contribute to the
modulation of tumor dormancy, remains largely unknown.
Recently, two intriguing studies indicated that matricellular
proteins play a critical role in regulating the quiescent state
and enabling dormant DTCs to undergo metastatic growth
(Boyerinas et al., 2013; Ghajar et al., 2013).
Ghajar et al. reported that there are two distinct sub-
vascular niches when DTCs extravasate at the target met-
astatic sites. The mature microvascular niche provides
suppressive cues to inhibit cell proliferation and induces the
sustained quiescence of DTCs, whereas the sprouting
neovasculature niche provides stimuli that activate DTCs
and promote micrometastatic outgrowth. Among these dor-
mancy-promoting and -inhibiting niches, several matricellular
proteins, including thrombospondin-1 (TSP-1) and periostin
(POSTN), play crucial roles in regulating DTC dormancy.
TSP-1 is enriched in the basement membrane of mature
microvessel stalks and maintains DTCs in a dormant state;
however, TSP-1 levels are markedly decreased at the
sprouting neovascular tips of newly forming vessels. Inter-
estingly, they also found an increased distribution of matri-
cellular proteins, such as POSTN, tenascin-C and SPARC,
together with ﬁbronectin and TGF-β1, around these growing
tips. The authors further provided evidence that high POSTN
and active TGF-β1 expression surrounding neovascular tip
cells enables DTCs to exit from dormancy and triggers
metastatic relapse (Ghajar et al., 2013) (Fig. 1). At nearly the
same time, Boyerinas and colleagues demonstrated that
osteoblast-derived osteopontin (OPN) assists acute lym-
phoblastic leukemia (ALL) cells in anchoring to the bone
marrow endosteal niche and promotes tumor dormancy
(Fig. 1). OPN neutralization increases leukemia burden by
decreasing dormant ALL cells in mice, but reduces minimal
residual disease in leukemic mice when synergizes with Ara-
C-based chemotherapy (Boyerinas et al., 2013). These
results suggest that matricellular proteins TSP-1, POSTN,
tenascin-C, SPARC and OPN exhibit critical roles in regu-
lating tumor dormancy.
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Two questions arising from these observations are why
do so many matricellular proteins actively contribute to the
regulation of tumor dormancy, and where do they exert
location-speciﬁc effects on dormancy? Matricellular proteins
are a set of non-structural extracellular matrix (ECM) pro-
teins, mainly including thrombospondins (TSPs), OPN, te-
nascins, SPARC, POSTN and CCNs, which do not exert a
primary role in tissue architecture but regulate similar bio-
logical functions in response to external stimuli during
embryonic development, tissue injury, inﬂammation and
tumor progression (Bornstein, 1995). TSP-1 is a potent
inhibitor of neovascularization and tumorigenesis (Isenberg
et al., 2009), whereas POSTN acts as a potent pro-angio-
genic factor by binding to integrins to activate PI3K/Akt and
FAK signaling pathways, thereby promoting cell survival and
angiogenesis (Bao et al., 2004; Shao et al., 2004). Tenascin-
C, SPARC, OPN and CCNs are also actively involved in
modulating angiogenesis (Chiodoni et al., 2010). Current
evidence demonstrates that tumor blood vessels are
important routes for DTCs to metastasize to distant sites and
are indispensable for tumor development (Liu and Ouyang,
2013). Perivascular niche has been shown to be a critical
local microenvironment to regulate self-renewal of cancer
stem cells (CSCs) (Calabrese et al., 2007). Interestingly,
tenascin-C and POSTN are important regulators of CSC
stemness in metastatic niches (Oskarsson et al., 2011;
Ouyang et al., 2010; Malanchi et al., 2012; Wang and Ouy-
ang, 2012; Wang et al., 2013). Thus, these matricellular
proteins may be key components in perivascular niches and
contribute to the maintenance or inhibition of dormancy by
regulating endothelial cell proliferation, angiogenic switch
and DTC self-renewal.
In bone marrow, the endosteal niche is important for
hematopoietic stem cells (HSCs) to maintain quiescence,
whereas the perivascular niche accommodates more acti-
vated HSCs. Quiescent HSCs reside preferentially at the
endosteal region where bone-lining osteoblasts and their
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Figure 1. Tumor dormancy and matricellular proteins. Three types of tumor dormancy exist: cellular dormancy (A), angiogenic
dormancy (B) and immunological dormancy (C). Cancer cells enter into G0–G1 arrest during cellular dormancy. Angiogenic dormancy
is regarded as a state during which pro-angiogenic factors are balanced with anti-angiogenic factors, resulting in poor vascularization
and limited tumor size. Immunological dormancy refers to a state during which the active immune system clears most of tumor cells,
leading to an equilibrium between cell population and immunological clearance. (D) DTCs exit from tumor dormancy and turn into
metastatic outgrowths. (E) TSP-1 is rich in mature vessel stalks and maintains disseminated breast cancer cells in a dormant state,
whereas POSTN, tenascin-C and TGF-β1 are distributed at neovascular tips and enable DTCs to escape from the dormant state and
undergo metastatic outgrowth. (F) OPN assists acute lymphoblastic leukemia cells in anchoring to the bone marrow endosteal niche
and promotes dormancy.
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Interestingly, bone marrow microenvironment is also a criti-
cal reservoir for DTCs. When metastasizing to the bone,
DTCs take shelter in HSC niches in bone marrow and adopt
similar mechanisms to those used by HSCs for homing to
bone marrow. That is to say, DTCs may occupy and remodel
preexisting physiological HSC niches to help them survive
and subsequently grow and metastasize (Wan et al., 2013).
OPN has been shown to be a critical component of the HSC
niche and to negatively regulate HSC numbers (Nilsson
et al., 2005). POSTN, SPARC, tenascin-C, TSP-1 and CCNs
can also be secreted by several bone marrow-derived cells,
and their aberrant expression is related to DTC bone
metastasis. Administration of anti-POSTN antibody or
knockdown of tenascin-C inhibits bone metastasis of breast
cancer in mice. Thus, the detailed functions of OPN in HSC
niches and ALL cell dormancy indicate that other matricel-
lular proteins may also contribute to bone marrow niches and
DTC dormancy in bone. Whether these matricellular proteins
regulate tumor dormancy in bone marrow HSC niches, per-
ivascular locations and other speciﬁc metastatic niches
deserves systemic investigation.
How do matricellular proteins maintain dormant tumor
cells in a quiescent state or reactivate them to metastatic
outgrowth? As a class of structurally unrelated ECM pro-
teins, matricellular proteins serve as links between the ECM
and cells to regulate cell-cell and cell-matrix interactions, and
their functions are highly dependent upon the cues from local
microenvironment. These matricellular proteins are often
needed for ECM remodeling during embryonic development
and their expressions are highly induced at sites of injury,
inﬂammation or tumors within the adult organism. An
excessive or uncontrolled matricellular proteins’ function
contributes to aberrant remodeling and homeostasis of tis-
sue microenvironment in various inﬂammatory diseases and
tumors. Matricellular protein knockout mice are often viable,
but typically exhibit abnormal responses to mechanical
stress, wound healing, inﬂammation and tumor metastasis.
POSTN, for example, can directly interact with collagen I,
ﬁbronectin and Notch1 via its EMI domain and interact with
tenascin-C and BMP-1 via its FAS1 domains (Norris et al.,
2007; Maruhashi et al., 2010; Kii et al., 2010; Tanabe et al.,
2010). POSTN and lysyl oxidase (LOX) precursor bind to
ﬁbronectin, stabilizing LOX precursor and allowing it to be
proteolyzed into mature LOX. Thus, POSTN can recruit
BMP-1 onto the ﬁbronectin matrix to promote LOX activity for
collagen cross-linking (Kudo, 2011; Conway et al., 2014).
This scaffold and remodeling function of POSTN may help
us to understand its mechanism in regulating inﬂammation
and tumor metastasis. For example, POSTN is highly
expressed in various inﬂammatory tissues and regulates
TGF-β signaling to modulate Th2 inﬂammatory response
(Masuoka et al., 2012; Conway et al., 2014). POSTN is also
a critical component in the metastatic niche that promotes
DTC metastatic outgrowth (Bao et al., 2004; Ruan et al.,
2009; Malanchi et al., 2012; Wang and Ouyang, 2012; Wang
et al., 2013). Moreover, POSTN can promote DTC self-
renewal and metastatic formation by augmenting Wnt sig-
naling pathway (Malanchi et al., 2012). Interestingly, TSP-1
(Isenberg et al., 2009), tenascin-C (Oskarsson et al., 2011),
SPARC (Rivera et al., 2011), OPN (Song et al., 2009) and
CCNs (Jun and Lau, 2011) are also actively involved in ECM
remodeling and regulating cell survival- and proliferation-
related signaling pathways in inﬂammatory diseases and
tumors. Therefore, the prominent roles of these matricellular
proteins in inﬂammatory responses, tumor dormancy and
metastasis are to remodel the biophysical and biochemical
properties of tissue microenvironment; recruit Wnt, Notch,
TGF-β or other ligands to modulate their signaling; and bind
with their cell surface receptors to regulate survival- and
proliferation-related pathways inside the cells by interacting
with growth factors, proteases, cell surface receptors and
other structural matrix proteins, as well as themselves. A
more detailed understanding of the functions of matricellular
proteins in inﬂammatory and metastatic microenvironments
will help to elucidate the role of matricellular proteins in
regulating tumor dormancy.
The work by Ghajar et al. and Boyerinas et al. greatly
expanded our understanding of the roles of tissue micro-
environmental cues in regulating tumor dormancy and
subsequent metastatic growth. The identiﬁcation of matri-
cellular proteins in regulating ECM homeostasis and
remodeling speciﬁc organ niches during tumor dormancy
provides useful extracellular targets for the development of
therapeutic interventions to induce or maintain DTCs in a
dormant state, or alternatively to activate and then eradi-
cate dormant DTCs.
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